Press Releases

Press Releases

New functionality provides a straightforward method for radiologists to indicate the first imaging test, or sign or symptom that triggered subsequent workup and diagnosis of breast cancer

Apollo introduces a groundbreaking new eBook, Delivering relevant medical images across the continuum of care, which introduces a paradigm shift in enterprise imaging, explaining how a multi-disciplinary, patient-centric approach supports thinking beyond the radiology workflow to reflect both the workflows of other specialties and medical encounters.

Patients and Physicians in Northeast Florida have been demanding a new type of patient-centric healthcare service. By partnering with Idonia, Precision Imaging Centers is answering that demand.

 

TIMS Medical releases TIMS MVP 5.0, a major new upgrade to its flagship product for recording, editing and archiving MBS, FEES and endoscopy studies in high-resolution video with synced audio.

Orthoscan announced the End of Life (EOL) plan for its Orthoscan FD, FD-OR, Mobile DI (MDI), and FD Pulse Mini C-Arms. 

Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced the successful completion of patient enrollment in the company’s pivotal phase 3 clinical study, SPARKLE, with the lead candidate drug Orviglance®.

When using this service, patients have the ability to upload and share data without limitations. From radiology CDs to PDFs or JPG files, patients can use their smartphone connected to the Patient Image Exchange app and upload images, share lab results, immunizations records, nurses’ notes, dental images and much more.

 

Award-winning company expands its U.S. warehouse with high-quality Mini C-Arm refurbishment center.

Nov 29, 2022 | Submitted by: Ascelia Pharma

23 November 2022: Ascelia Pharma AB (publ) – a biopharmaceutical company focused on improving the life of people living with rare cancer conditions –  is presenting results from its Orviglance* Food Effect study at the RSNA conference 2022 (Radiological Society of North America – 27 November – 1 December Chicago, Illinois). The study evaluates the effect of food intake on the absorption and signal intensity of Orviglance, a manganese-based MRI contrast agent, and successfully concludes that image enhancement is not impacted by a light meal.

With a mission to provide best-in-class clinical interpretation solutions, Digisonics provides over 2,000 active users a vendor neutral platform that consolidates multiple systems to optimize the physician workflow and ultimately improve patient care.

The contract comprises a radiology module and a region-wide multimedia solution to store medical images and multimedia across all medical specialties.

Evohealth, a trailblazer in incorporating new technology in Healthcare IT software, announced it has exceeded its first milestone of more than 100 customers with over 200 locations.

Fujifilm’s unique SYNAPSE® Dose 2.0 offers a comprehensive system for monitoring and managing patient radiation exposure across different imaging modalities.

They will utilize the platform’s radiology and cardiology modules as well as the multi-media archive VNA, to store all medical images throughout the health system.

The radiology module will be used throughout the hospital and be part of a regional collaboration network initiative in the Limburg area.

TeraRecon, the leading provider of AI-driven advanced visualization solutions, today announced the debut of their Clinical Training Cloud for affordable imaging-based education initiatives across the U.S. and Europe.

The leading provider of AI-driven advanced visualization solutions, today announced the expansion of their distribution offering to Change Healthcare customers for their AI-powered Intuition Subscription.

New allowance includes continuous synchronization of AI findings between the image interpretation viewer, physician, and diagnostic report.

On the heels of receiving the first New Technology Add-on Payment from CMS for an AI powered software system, this award further validates the real world benefits Viz.ai brings to stroke patients.

Aug 27, 2020 | Submitted by: TeraRecon

TeraRecon launches new Intuition Titanium suite, a new inclusive subscription offering that includes a robust set of enterprise AI capabilities.

Hadassah Medical Center and Assuta Medical Center, two of the leading healthcare providers in Israel, have decided to digitize their pathology departments with a solution from international medical imaging IT and cybersecurity company Sectra.

International medical imaging IT and cybersecurity company Sectra has signed a digital pathology contract with Region Västmanland in Sweden

International medical imaging IT and cybersecurity company Sectra has signed a ten-year enterprise imaging contract with St. Claraspital in Basel, Switzerland.

TeraRecon EnvoyAI and Northstar technologies are renamed with SymphonyAI Group shared branding in the next step toward connecting B2B systems of intelligence for improved care.

Siemens Healthineers and Geisinger have established a 10-year Value Partnership to advance and support elements of Geisinger’s strategic priorities related to continually improving care for their patients, communities, and the region.

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a contract with Sanford Health to add cardiology to their existing enterprise imaging solution.

The solution will support workflow optimization and increased reading efficiency across multiple geographic locations, thereby improving diagnostics and patient care.

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a five-year medical imaging contract with St. Elizabeth Healthcare. Sectra will install the radiology and breast imaging modules of its enterprise imaging solution throughout the healthcare provider's five hospitals and numerous outpatient centers.

Solution Provides Essential Mobility for Radiologists Displaced from Standard Work Environments. 

VIDA Diagnostics, Inc., the leader in AI-powered lung imaging analysis, today announced an $11M initial close of its Series C financing.